Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years*

✍ Scribed by Klonoff, David C.; Buse, John B.; Nielsen, Loretta L.; Guan, Xuesong; Bowlus, Christopher L.; Holcombe, John H.; Wintle, Matthew E.; Maggs, David G.

• Book ID: 118230785
• Publisher: Informa plc
• Year: 2007
• Tongue: English
• Weight: 740 KB
• Volume: 24
• Category: Article
• ISSN: 0300-7995
• DOI: 10.1185/030079908x253870